Kenyatta University Student Found Dead After Disappearing for Days

The Pharmacy and Poisons Board (PPB) has raised a red flag over the quality of a specific batch of Sure lubricated condoms, issuing a directive to stop their use and distribution. 

This development comes after quality control tests revealed that the condoms, distributed under Kenya’s public health program, did not meet safety standards.

According to the PPB, the batch in question, identified as Batch Number 2405055, failed the critical “freedom from holes” test, a quality assurance procedure designed to detect defects that compromise the product's effectiveness. 

The findings prompted immediate action, with PPB Chief Executive Officer Dr. Fred Siyoi urging all stakeholders—including pharmaceutical outlets, healthcare facilities, and members of the public—to cease further use or distribution of this batch.

In a statement released on December 11, 2024, the PPB emphasized the importance of returning any remaining products from the affected batch to healthcare facilities or suppliers. 

This move is critical in preventing potential health risks, as defective condoms undermine efforts to combat sexually transmitted infections (STIs), including HIV/AIDS, and unintended pregnancies.

The Sure condoms in question are a key part of Kenya’s public health initiative, which provides free access to contraception in public hospitals, schools, and community health centers. 

The program is vital in addressing the nation’s demand for condoms, which health officials estimate at 424 million annually. 

However, with the average Kenyan man using just 14 condoms per year—far below the recommended 40—the recall may further challenge these efforts.

This is not the first time Kenya has faced quality concerns regarding condoms. 

A similar recall occurred in 2019, when the Kenya Medical Supplies Authority (KEMSA) withdrew batches due to substandard quality. 

Despite these setbacks, the government remains committed to maintaining the integrity of its sexual health programs.

The recall highlights the need for stringent quality checks in the manufacturing and distribution of health products. 

With a significant portion of the population relying on free distribution programs, ensuring reliability is critical to public trust and health outcomes. 

The PPB has assured the public that it will work closely with stakeholders to address the situation and prevent future occurrences.

Health authorities urge the public to stay vigilant and report any issues with health products to ensure continued safety and efficacy in combating Kenya’s health challenges.